Phagos
Phagos
Phagos is developing bacteriophage therapies to combat antibiotic-resistant bacterial infections.
About
Technology stack
detected 2026-06-30No comments yet. Be the first to share your take.
What does Phagos do?
Phagos is a biotechnology company focused on developing novel bacteriophage therapies to address the growing threat of antibiotic-resistant bacteria. Their approach leverages the natural predators of bacteria, phages, to create targeted and effective treatments for infections that are no longer responsive to conventional antibiotics.
How much funding has Phagos raised?
Phagos has raised a total of $29M in funding. The most recent round on record is Series A.
Where is Phagos headquartered?
Phagos is headquartered in Boston, United States.
When was Phagos founded?
Phagos was founded in 2021.
What industry does Phagos operate in?
Phagos operates in Biotech, MedTech, HealthTech, Drug Discovery, Phage Therapy, Antibiotic Resistance.
How many employees does Phagos have?
Phagos has approximately 74 people on record.